Allergies & Immune Skin Disorders
Allergic contact dermatitis, drug eruptions, autoimmune skin diseases, urticaria, biologics, patch testing, and immune-related skin conditions.
Acute Urticaria: IgE-Mediated and Non-IgE-Mediated Pathways with Evidence-Based Management
What dermatologists should know about acute urticaria: clinical features, staging, and treatment selection....
Acute Urticaria: Sudden Hive Outbreaks
Acute Urticaria: clinical presentation, differential diagnosis, and evidence-based treatment protocols for dermatologist...
Allergic Contact Dermatitis: Clinical Considerations and Management
Treating allergic contact dermatitis: indications, techniques, expected outcomes, and evidence-based protocols....
Angioedema: Bradykinin-Mediated vs. Histaminergic Pathways & Treatment
Angioedema: clinical presentation, differential diagnosis, and evidence-based treatment protocols for dermatologists....
Atopic Dermatitis Immunology: Th2 Cytokines, Dupilumab & JAK Inhibitors
Atopic Dermatitis Immunology — 3% of adults and 10-20% of children, with rising prevalence . 3%, 20%...
Autoimmune Urticaria: Anti-IgE/FcεRI Antibodies & Omalizumab Response
Treating autoimmune urticaria: 40% of CSU patients have autoimmune pathophysiology. Outcome data and clinical pearls....
Cholinergic Urticaria: Heat and Exercise-Induced Hives
Cholinergic Urticaria — 10% of the population experiencing urticaria (making it the . 4 mm, 30 minutes...
Cholinergic Urticaria: Heat and Sweat-Triggered Urticaria Management
Managing cholinergic urticaria: treatment algorithms, dosing considerations, and patient monitoring guidelines....
Chronic Spontaneous Urticaria: Omalizumab Therapy & Clinical Management
Chronic Spontaneous Urticaria: diagnosis, staging, and current treatment options — a clinical dermatology reference....
Chronic Urticaria: Long-Lasting Hives Management
Chronic Urticaria in clinical practice: 95% of cases (termed "chronic spontaneous urticaria"). Expert protocols and outc...
Cold Urticaria: Hives from Cold Exposure
Cold Urticaria in practice: evaluation, treatment selection, monitoring, and follow-up for dermatologists....
Cold Urticaria: Ice Cube Testing, Critical Temperature Threshold & Anaphylaxis Risk
What dermatologists need to know about cold urticaria: 3% of the general population Protocols and clinical pearls for de...
Cutaneous Lupus Erythematosus: Localized and Systemic Manifestations
Treating cutaneous lupus erythematosus: 25% of systemic lupus erythematosus (SLE) patients and affec. Outcome data and c...
Dermatitis Herpetiformis: Gluten-Sensitive Dermatitis & Celiac Disease Link
Dermatitis Herpetiformis: 25% of celiac disease patients and represents the most commo. Current management protocols and...
Dermatographism: Writing on Skin Condition
Dermatographism Writing On Skin Condition — expert clinical reference covering diagnosis, treatment options, and patient...
Dermatomyositis: Autoimmune Myopathy with Pathognomonic Skin Findings
Dermatomyositis — 40% of adult patients diagnosed with DM have underlying mali. 40%, 90% Protocols and clinical pearls f...
DRESS Syndrome: Delayed Drug Reaction with Systemic Involvement and Viral Reactivation
DRESS Syndrome: 80% of DRESS cases; cross-reactivity within the class is 20-. From diagnosis to management — a dermatolo...
DRESS Syndrome: Drug Reaction with Systemic Symptoms
What dermatologists need to know about dress syndrome: 15% of severe cutaneous adverse reactions Protocols and clinical ...
Dupilumab for Atopic Dermatitis: EASI-75 Response, Dosing & Long-Term Efficacy
Expert clinical review of dupilumab for atopic dermatitis: diagnostic approach, management protocols, and outcome data....
Exanthematous Drug Eruption: Most Common Cutaneous Drug Reaction with Type IV Pathophysiology
Exanthematous Drug Eruption: diagnosis, staging, and current treatment options — a clinical dermatology reference....
Fixed Drug Eruption: Recurring Medication Reaction
Managing fixed drug eruption: treatment algorithms, dosing considerations, and patient monitoring guidelines....
Fixed Drug Eruption: Tissue-Resident Memory T Cell Mediated Localized Drug Reaction
How to evaluate and treat fixed drug eruption: clinical features, diagnostic criteria, and treatment algorithms....
Fragrance Allergy and Fragrance-Induced Dermatitis: Clinical Recognition and Management
Treating fragrance allergy and fragrance-induced dermatitis: 8% of the general population and 8-12% of dermatitis clinic...
Intradermal Testing: Assessment of IgE-Mediated Drug Allergy
Expert review: intradermal testing — important dermatological condition requiring careful clinica. Protocols, dosing, an...
Latex Allergy: Type IV and Type I Reactions in Clinical Practice
Latex Allergy: clinical presentation, differential diagnosis, and evidence-based treatment protocols for dermatologists....
Linear IgA Bullous Dermatosis: IgA-Mediated Subepidermal Blistering
Expert review: linear iga bullous dermatosis — important dermatological condition requiring careful clinica. Protocols, ...
Morbilliform Drug Eruption: Common Medication Rash
Morbilliform Drug Eruption — 50% of all drug reactions and characterized by widespread, s. 50%, 14 days...
Nickel Allergy: Epidemiology, Pathophysiology, and Evidence-Based Management
Nickel Allergy: diagnosis, staging, and current treatment options — a clinical dermatology reference....
Nickel Allergy: Most Common Metal Contact Dermatitis and Avoidance Strategies
Anaphylaxis Skin Signs: clinical evaluation, treatment protocols, and evidence-based management for dermatologists....
Patch Testing in Dermatology: Methodology, Interpretation, and Clinical Applications
Treating patch testing in dermatology: 20% of the global population experiences contact dermatitis . Outcome data and cl...
Pemphigoid Gestationis: Pregnancy-Associated Autoimmune Bullous Dermatosis
Pemphigoid Gestationis: important dermatological condition requiring careful clinica. From diagnosis to management — a d...
Photoallergy vs Phototoxicity: Pathophysiology, Clinical Diagnosis, and Management
Photoallergy vs Phototoxicity in practice: evaluation, treatment selection, monitoring, and follow-up for dermatologists...
Photopatch Testing: Diagnosis of Photocontact and Persistent Light Reactions
How to diagnose and manage photopatch testing: important dermatological condition requiring careful clinica. Dermatologi...
Phototherapy for Immune Skin Conditions: UVB, PUVA, Laser Phototherapy
How to diagnose and manage phototherapy for immune skin conditions: 75% of patients with psoriasis after 24-30 treatment...
Poison Ivy Dermatitis: Urushiol Oil Reaction and Plant Identification
How to diagnose and manage fragrance allergy hidden allergens in products: clinical features, workup, and therapeutic ap...
Poison Ivy Dermatitis: Urushiol Oil Type IV Hypersensitivity and Management
Expert review: poison ivy dermatitis — important dermatological condition requiring careful clinica. Protocols, dosing, ...
Preservative Allergy: Formaldehyde and Paraben Contact Sensitization
Preservative Allergy in clinical practice: important dermatological condition requiring careful clinica. Expert protocol...
Stevens-Johnson Syndrome: Drug-Induced Severe Cutaneous Reaction with Medical Emergency Management
Stevens-Johnson Syndrome: diagnosis, staging, and current treatment options — a clinical dermatology reference....
Stevens-Johnson Syndrome: Severe Drug Reaction
Stevens-Johnson Syndrome: clinical presentation, differential diagnosis, and evidence-based treatment protocols for derm...
Toxic Epidermal Necrolysis: >30% BSA Epidermal Necrosis and Medical Emergency
Expert review: toxic epidermal necrolysis — important dermatological condition requiring careful clinica. Protocols, dos...